Microcide Pharmaceuticals (MCDE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Microcide Pharmaceuticals (MCDE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Dwyer who wrote (117)	9/10/1997 10:54:00 AM
From: scaram(o)uche	of 186

No, you're not wrong. The signal transduction program was an Ortho program prior to the MCDE relationship, and MCDE has about one FTE working on the project. However, I haven't done enough homework on the mechanism of action of the second trial candidate from the Ortho program, the methicillin potentiator or MC252. I have a company graphic showing that it targets something between transcription and the expression of PBP2a. Gotta do more homework on this sucker, and I posted the abstract hoping that it would tweek someone's memory or vast knowledge. ;-) Thank, John. Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next